5Mumcu G,Sur H,Karacayli IU,et aI.A com- posite index for determining the impact of oral ulcer activity in Behcet' s disease and recurrent aphthous stomatitis[J].J O- ral Pathol Med,2009,38:785-791.
5Misumi M,Hagiwara E,Takeno M.Cytokine production profile in patients with Behcet's disease treated with ifnliximab[J].Cytokine,2003,24(5):210-218.
6Ribi C,Sztajzel R,Delavelle J,et al.Efficacy of TNF-alpha blockade in cyclophosphamide resistant neuro-Behcet disease[J].J Neurol Neurosurg Psychiatry,2005,76(12):1733-1735.
7Ahn JK,Seo JM,Yu J.Down-regulation of IFN-gammaproducing CD56A + T cells after combined low-dose cyclosporine/prednisene treatment in patients with Behcet's uveitis[J].Invest Ophthalmol Vis Sci,2005,46 (7):2458-2464.
8Imamura Y,Kurokawa MS,Yoshikawa H,et al.Involvement of Thl cells and heat shock protein 60 in the pathogenesis of intestinal Behcet's disease[J].Clin Exp Immunol,2005,139(2):371-378.
9Hamzaoui K,Hamzaoui A,Guemira F,et al.Cytokine profile in Behcet's disease patients.Relationship with disease activity[J].Scand J Rheumatol,2002,31 (4):205-210.
10Liao-Yuan Wang,Dong-Bao Zhao,Jun Gu,Sheng-Ming Dai.Clinical characteristics of Beh?et’s disease in China[J]. Rheumatology International . 2010 (9)
